Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Eli Lilly Corp. buy gerihouse

Start price
€103.80
24.06.19 / 50%
Target price
€130.79
06.09.19
Performance (%)
0.94%
End price
€104.32
06.09.19
Summary
This prediction ended on 06.09.19 with a price of €104.32. During the runtime of the prediction for Eli Lilly Corp. the price only changed by 0.94%. gerihouse has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. A total of €0.46 was paid as dividends for this prediction. gerihouse has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Eli Lilly Corp. 1.625% 1.625% 131.935% 358.371%
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

According to gerihouse what are the pros and cons of Eli Lilly Corp. for the foreseeable future?

Pros
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Future proof or reliable business model
Small cyclical dependencies
Well known brand
Revenue growth >5% per year expected
Cons

Comments by gerihouse for this prediction

In the thread Eli Lilly Corp. diskutieren
Prediction Buy
Perf. (%) 0.94%
Target price 130.790
Change
Ends at 06.09.19

seit über 100 Jahren Dividende

Der amerikanische Pharmakonzern Eli Lilly and Company (ISIN: US5324571083, NYSE: LLY) wird am 10. September 2019 eine Dividende von 64,5 US-Cents je Aktie für das dritte Quartal 2019 ausbezahlen. Record date ist der 15. August 2019.

Auf Jahressicht erhalten die Aktionäre 2,58 US-Dollar. Dies entspricht einer aktuellen Dividendenrendite in Höhe von 2,23 Prozent beim derzeitigen Aktienkurs von 115,56 US-Dollar (Stand: 20. Juni 2019). Eli Lilly zahlt seit dem Jahr 1885 ununterbrochen eine Dividende an seine Aktionäre aus.

Eli Lilly and Company gehört zu den größten Pharmaunternehmen weltweit und ist seit 1960 auch in Deutschland vertreten. Der Konzern mit Firmensitz in Indianapolis ist 1876 von dem Pharmakologen, Offizier und Unternehmer Eli Lilly in Indianapolis gegründet worden. Im ersten Quartal des Fiskaljahres 2019 betrug der Umsatz 5,09 Mrd. US-Dollar (Vorjahr: 4,96 Mrd. US-Dollar), wie am 30. April berichtet wurde. Der Gewinn (Non-GAAP) lag bei 1,24 Mrd. US-Dollar (Vorjahr: 1,29 Mrd. US-Dollar).

Seit Anfang des Jahres 2019 weist die Aktie an der Wall Street ein Kursminus von 0,14 Prozent bei einer aktuellen Marktkapitalisierung von 112,2 Mrd. US-Dollar auf (Stand: 20. Juni 2019).

Redaktion MyDividends.de



Prediction Buy
Perf. (%) 0.94%
Target price 145.000
Change
Ends at 06.09.19

Buy beendet

Prediction Buy
Perf. (%) 0.94%
Target price 130.790
Change
Ends at 06.09.19

Buy beendet

Current prediction by gerihouse for Eli Lilly Corp.

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€546.50
16.11.23
€690.00
16.11.24
32.06%
12:48

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative

Stopped prediction by gerihouse for Eli Lilly Corp.

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€370.05
04.11.22
€610.00
04.11.23
44.17%
05.11.23

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€213.80
18.01.22
€350.00
18.01.23
47.33%
23.09.22

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€173.98
25.01.21
€250.00
25.01.22
23.00%
17.01.22

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€126.32
18.03.20
€150.00
12.10.20
6.54%
12.10.20

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€98.78
13.10.19
€120.00
26.10.19
0.30%
26.10.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€104.32
06.09.19
€120.00
13.10.19
-5.58%
13.10.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€102.30
18.04.19
€120.00
24.05.19
3.46%
24.05.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€106.63
24.01.19
€126.28
04.04.19
6.26%
04.04.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€71.74
10.05.18
€99.22
06.09.18
32.15%
06.09.18

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€68.59
31.08.17
€80.00
10.11.17
3.37%
10.11.17

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€71.74
10.11.16
€85.00
18.04.17
8.26%
18.04.17

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€63.10
24.03.16
€90.00
08.08.16
16.05%
08.08.16

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€71.93
13.10.15
€90.20
04.01.16
4.66%
04.01.16

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€65.85
05.05.15
€83.00
22.07.15
19.78%
22.07.15

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€49.89
11.09.14
€60.00
24.11.14
8.90%
24.11.14

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€39.56
09.10.12
€45.00
21.02.13
5.46%
21.02.13

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€34.30
04.07.12
€40.00
05.09.12
8.03%
05.09.12

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative